Anthrax
Researchers' work from USA Scientific focuses on anthrax
Published in Gene Therapy Weekly, July 9th, 2009
"The modulation of cellular processes by small molecule inhibitors, gene inactivation, or targeted knockdown strategies combined with phenotypic screens are powerful approaches to delineate complex cellular pathways and to identify key players involved in disease pathogenesis. Using chemical genetic screening, we tested a library of known phosphatase inhibitors and identified several compounds that protected Bacillus anthracis infected macrophages from cell death," scientists in the United States report.
"The most potent compound was assayed against a panel of sixteen different phosphatases of which CD45 was found to be most sensitive to inhibition. Testing of a known...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-07-09)
More Articles from Gene Therapy Weekly
- World Journal of Gastroenterology
Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells - Amyotrophic Lateral Sclerosis
Findings in amyotrophic lateral sclerosis reported from Mayo Clinic, Medical Department - Angiogenesis
Data from University of Connecticut advance knowledge in angiogenesis - Bioengineering
Study results from K. Kimura et al provide new insights into bioengineering - Breast Cancer
Study results from J. Lin and colleagues in the area of breast cancer published - Colon Cancer
Data from Beaujon University provide new insights into colon cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
